| Industry | 制造业 | ||||||||||||||||||||||||
| Company Introduction | 华北制药股份有限公司属于医药化工行业.主要产品有青霉素类、头孢类、维生素类等医药及其他物流贸易.从1987年开始,企业相继建成产品检测中心.科研开发中心、完成了对青霉素发酵、提系统的技术发生,使青霉素生产达到和接近国际水平.1990年进入国家一级企业行列;1992年被国家定为特大型企业.是全国500家最大的工业企业和最佳效益工业企业之一。 | ||||||||||||||||||||||||
| Main Business | 医药产品的研发、生产和销售等业务。 | ||||||||||||||||||||||||
| Legal Representative | 王立鑫 | ||||||||||||||||||||||||
| Top Executives |
|
||||||||||||||||||||||||
| Top 5 Shareholder |
|
||||||||||||||||||||||||
| Company Secretary | 肖志广 | ||||||||||||||||||||||||
| Solicitors | 北京德恒律师事务所 | ||||||||||||||||||||||||
| Auditors | 中天运会计师事务所（特殊普通合伙） | ||||||||||||||||||||||||
| Tel No | 0311-87173756;0311-85992839 | ||||||||||||||||||||||||
| Fax No | 0311-86060942 | ||||||||||||||||||||||||
| Website | www.ncpc.cn | ||||||||||||||||||||||||
| xiaozhiguang@ncpc.com；yangjingcw@ncpc.com | |||||||||||||||||||||||||
| Company Address |
|
||||||||||||||||||||||||
| Listing Date | 14/01/1994 | ||||||||||||||||||||||||
| Shares Capital |
|
||||||||||||||||||||||||
| EPS(RMB)* | ¥ 0.003 | ||||||||||||||||||||||||
| DPS(RMB)* | ¥ 0.010 | ||||||||||||||||||||||||
| NBV Per Share(RMB)* | ¥ 3.098 | ||||||||||||||||||||||||
| Market Capitalization(RMB) | 9.196B |
 |
Only Chinese content is avaliable |
|
N
/
N
: Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SH-HK Ex-Northbound trade (sell only)
|
|
|
N
/
N
: Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
|
|
| * | Unadjusted Data |
| Information provided by: etnet | ||
| Terms and Conditions | ||
| Risk Disclosure: |
| The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone. |
| Disclaimer: |
| This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources, Nanyang Commercial Bank Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information. |